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Presentation of Case

Dr.Viswanathan Nagarajan (Infectious Diseases
fellow): A 39-year-old previously healthy male presented to the
emergency room for sudden onset left sided chest pain, cough
with blood tinged sputum and shortness of breath, which started
abruptly six hours prior to the presentation. He had been to
another emergency room three days prior with myalgia, fever,
headache, nausea, vomiting and diarrhea. Rapid influenza
screen had been negative at that hospital. Nevertheless, he
was discharged on oseltamivir. Now, shortness of breath was
at rest and the chest pain was associated with cough and deep
breathing. He also continued to have diarrhea and vomiting.
Apart from having a 27 pack-year history of smoking, marijuana
use and consuming a pint of alcohol every day, he had no history
of intravenous drug use. He lived with his girlfriend, and denied
promiscuous sexual activity or sex with males. He denied any
travel outside of the US, or having pets at home. He had no
known drug allergies.
His temperature was 38.8° Celsius, heart rate 130 beats/min,
respiratory rate 33 breaths/min, blood pressure 151/83 mm
Hg, and oxygen saturation 93% on room air (FiO2 21%). The
patient was in moderate respiratory distress and was seen using
accessory muscles of respiration. He was alert, but unable to
speak up as his voice was feeble. He had no signs of clubbing or
generalized lymphadenopathy. No needle tracks were observed.
Lung auscultation revealed equal air entry on both sides with no
changes in his inspiration to expiration ratio. Bilateral crackles
and wheezing were noted on the entire left side. On percussion,
no dullness or resonance was noted.

Diagnostic Approach

Dr. Julio Ramirez (Chief, ID): At this point, let’s say you
are working in the emergency room and are presented with this
patient and do not have imaging or laboratory values yet. What
do you think?
Dr. Srini Dontineni (ID fellow): It looks like a gentleman
of 39 years without a history of medical problems who presents
with fever, hemoptysis, myalgias and everything that appears
to be an acute infectious process of the respiratory system and
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community-acquired pneumonia (CAP). It looks bacterial and
his recent influenza test was negative, so this is unlikely viral, but
rather bacterial. The differential for bacterial CAP in this patient
includes typical pathogens, such as, Streptococcus pneumoniae,
Haemophilus influenzae and Moraxella catarrhalis as well as
atypical pathogens, such as, Chlamydia pneumoniae, Legionella
pneumophila and Mycoplasma pneumoniae.
Dr. Veronica Corcino (ID fellow): With an acute
presentation of fever, nausea, and vomiting and developing
respiratory symptoms that were more remarkable three days
after being discharged from the emergency room, what is
important for me is that he is a smoker (two or three packs per
day). He could be colonized with many organisms. He also
takes a half pint of alcohol and uses marijuana, so I agree with
Dr. Dontineni’s presentation that because of the respiratory
symptoms, it could be pneumonia. What type of pneumonia?
Maybe he started with some viral symptoms. He mentioned
that he started with myalgias and fever the first time he went
to the emergency room. I don’t know if he was really negative
for influenza, but he was discharged on oseltamivir. They may
have been thinking about a false negative because of a known
exposure to someone else. But the point is he may have had
some viral infection and then developed a bacterial pneumonia.
He also may have had so much alcohol that he lost consciousness
and aspirated anaerobic bacteria, such as Peptostreptococcus,
Fusobacterium, Bacteroides, or Prevotella. I would also consider
Klebsiella pneumoniae. I also don’t know if days before he had
had a dental procedure? His symptoms now may be his immune
system responding to Pneumocystis jiroveci pneumonia (PCP)
or a bacterial infection, and specifically his pleuritic pain due
a pneumothorax or to an abscess. As you know, communityacquired methicillin-resistant Staphylococcus aureus, and
Streptococcus species including S. pyogenes, and S. anginosus
may cause a severe pneumonia. Atypical organisms were
mentioned and I agree.
I was thinking how to tie his vomiting and diarrhea with his
respiratory symptoms. Legionella would explain both. If he
had HIV, I would inquire about his GI symptoms. He is not a
known intravenous drug user, but he does smoke marijuana,
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so there is a suspicion. Of course, if blood cultures are positive
then he might have infective endocarditis, which is always in our
differential. I think a fungal etiology is less likely.
Dr. Ramirez: You ran through the chapter of communityacquired pneumonia (CAP). You told us almost all the
organisms that can cause CAP. Then, to both of you, if you can
tell me one consideration, what do you think happened with this
patient. What would be most likely?

unlikely. Another of you mentioned that since the patient
is immunocompromised we should consider PCP, but this
presentation is too acute to say that PCP should be in the
differential, unless he has a pneumothorax. I agree with the
comments that this could be post-influenza S. pneumoniae
or S. aureus. And I think the third most common pathogen
in this scenario is influenza. Even with influenza there are
associated cardiac complications with myocarditis, pericarditis,
or myocardial infarction, so any of that could be making this
presentation worse.

Dr. Dontineni: Pneumonia acquired in the community.
Dr. Corcino: With these respiratory symptoms, we need to see
the chest X-ray.
Dr. Ramirez: I know, but what would be the story? Don’t tell
me the differential.
Dr. Corcino: Acute viral syndrome that caused pneumonia.
Dr. Ramirez: I agree. The patient has a flu like syndrome
for which he went to the ER and they did a rapid influenza test
that was negative, but they are so convinced that it was a falsenegative test that they sent the patient home with oseltamivir.
So, it seems to me that the patient was having the influenzalike syndrome that is the classic post-influenza CAP. That’s the
story. Because the patient is a 39 year old with a respiratory
rate of 33, 92% saturation on 2L/min of oxygen with a cough,
you don’t need a chest X-ray to diagnose pneumonia. Unless the
patient had a pulmonary embolism at 3 o’clock in the morning,
how do you explain a drop in saturation to 93% on 2L/min in
a 39 year old? You have to have a massive VQ mismatch and
most likely it is pneumonia. The history is interesting when
he was in the ER of the other hospital. He doesn’t complain
of cough and all of a sudden at 3 o’clock in the morning he
developed chest pain; he woke up with chest pain. You know
this is classical for pneumococcal pneumonia. It is sudden
pain like a knife [stabbing sound]. So this seems to me to be a
case of post-influenza CAP due to S. pneumoniae, or possibly
S. aureus. The patient had blood in his sputum, so he may
have had necrotizing pneumonia from community-acquired
MRSA. Then the way that this is forming in my mind is that it is
community-acquired-MRSA due to USA 300 gene with PantonValentine leukocidin (PVL) toxin causing damage [1]. Then my
primary consideration is probably post-influenza CA-MRSA or
pneumococcal pneumonia.
On the CXR, we can expect to see cavities consistent with
necrotizing pneumonia. We have discussed that S. aureus is now
the second most common bacterial cause of CAP. So, when you
list the most common pathogens causing CAP, remember to list
S aureus, and when you say H. influenzae and M. catarrhalis,
also put S. aureus. This patient is too sick for a 39 year old to
have Mycoplasma pneumoniae or Chlamydia pneumoniae.
Legionella pneumophila, yes. It is not likely aspiration
pneumonia, which is more subacute. You can aspirate all you
want, but you will never be this hypoxic six hours later. You
need time to develop the abscess and progress. Overall, I would
consider these things, but from the long differential you listed,
there are a lot of things that this is not. It has to be some acute
organisms that can make a 39 year old severely sick.

Dr. Raff: Pneumococcal pneumonia classically has
hyperbilirubinemia associated with it and often patients appear
icteric at the onset. On the other hand, he has bilateral rales
[crackles] and with pneumococcal pneumonia you expect single
lobe involvement rather than bilateral. The rapid progression
of hypoxia with intercostal retractions and the bloody sputum
tends to be S. aureus as a necrotizing process. I agree that
H. influenza should also be considered [2]. Subsequently, it
has been shown that paralysis of the mucociliary border and
inactivity of pulmonary macrophages makes them susceptible
to organisms in the nasopharynx - and the organisms are
pneumococcus, S. aureus, H. influenzae, group A β- strep,
M. catarrhalis (more in children than adults), and Klebsiella
pneumoinae (which would explain the hemoptysis, especially in
an alcoholic).
Dr. Ramirez: Yes, there are a number of bacteria that can
cause pneumonia after having influenza. And that’s why H.
influenza has its name - because it was isolated during outbreaks
of influenza and it was thought to be the cause at a time before
viruses were discovered. With the emergence of communityassociated MRSA, there is a new concern.

Clinical Diagnosis

Post-influenza bacterial pneumonia

Hospital Course

Dr. Viswanathan: Initial labs were as follows. (Table 1) In
addition, his lactic acid was 2.7 mmol/L, and increased to 5.4
mmol/L after six hours. His arterial blood gas on 21% FiO2 had
a pH of 7.43, pCO2 of 26 mmHg, pO2 of 63 mmHg and HCO3 of
18 mmol/L. His total bilirubin was 14.1 mg/dL with direct being
8.7 mg/dL. Negative tests included an acute hepatitis panel,
a human immunodeficiency virus test, and Streptococcal and
Legionella urinary antigens. A rapid nasopharyngeal screen for
respiratory syncytial virus was also negative, but for influenza A
virus was positive.
Table 1 Initial labs for the patient in the emergency room.

Dr. Raghuram: One point I want to clarify–one of you
mentioned that the rapid flu test was negative, so it was
unlikely influenza, but the sensitivity of that test is between
50-70%, so just because it is negative doesn’t mean that it is
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WBC

3000 cells/mL

Hematocrit

45%

Platelets

121,000 cells/mL

Sodium

128 mmol/L

Potassium

3.8 mmol/L

Chloride

99 mmol/L

Creatinine

0.9 mg/dL

Glucose

183 mg/dL

Phosphate

1.0 mg/dL

AST

159 U/L

ALT

109 U/L

Total bilirubin

14.1 mg/dL

LDH

1888 U/L

ESR

4 mm/hr

ALT, alanine aminotransferase; AST aspartate aminotransferase;
ESR, erythrocyte sedimentation rate; LDH, lactate dehydrogenase;
WBC, white blood cell
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Figure 1 Chest radiograph of patient at presentation with respiratory distress.

Dr. Corcino: The only thing I would expect different in a
healthy young male being this sick would be a higher white
blood cell count.
Dr. Dontineni: The most notable abnormalities are his low
platelets and his low pO2.
Dr. Ramirez: This emphasizes what we just discussed;
that this patient is extremely sick with manifestations of CAP
including sepsis, organ failure, a lactic acid of 5.4, platelets close
to 100,000 cells/mL and a white blood cell count of only 3000
cells/mL. Again, any patient with severe CAP and neutropenia
is community-acquired MRSA until proven otherwise.
Dr. Viswanathan: His chest radiograph was reviewed.
(Figure 1)

Discussion

Dr. Dontineni: I don’t see any infiltrate, consolidation, or
pneumothorax. The costophrenic angles are clear and the
trachea is in the midline.
Dr. Corcino: The right side may have the beginning of an
infiltrate.
Dr. Ramirez: I am biased because after this presentation I
am expecting something to be on the chest x-ray. The patient
has left-sided chest pain and hemoptysis and he is telling me,
in essence, to look at his left side. The outer one third of the
lung is supposed to be very clear, and as you see, it is not clear
on the left side. To me he has an infiltrate. I don’t want to start
imagining cavities because it is easy to do when you look at the
edges of ribs.
Dr. Viswanathan: The report of the chest radiograph was
“patchy bilateral airspace opacities (left greater than right);
cardiomediastinal contours are within normal limits.” A CT
scan was obtained. (Figure 2)

Figure 2
(A) CT scan of the chest showing extensive bronchial dilatation and wall
thickening without pleural or pericaridial effusions,
(B).Extensive bilateral cavitating pneumonia most likely representing
septic emboli as well as mediastinal and hilar lymphadenopathy
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Dr. Ramirez: These findings on the CT scan are impressive but
you have to be able to find these changes on the portable film.
There is data to show that you can miss up to 4% of infiltrates
on a portable chest x-ray. There was a recent study of 300
pneumonia patients who received a portable chest radiograph
and a CT scan [3].
There are some areas of necrosis inside of this infiltrate;
perhaps an abscess or infiltrate around an airway with
bronchopneumonia. There is lateral bronchopneumonia with
upper lobe cavities highly suggestive of S. aureus USA 300 PVL
toxin positive. This patient had several criteria for pneumonia
due to this pathogen, so anti-MRSA treatment should be started
in the emergency room in this circumstance, in addition to the
other standard therapy for CAP.

For the first one or two days of antibiotics, no clinically relevant
pathophysiological progress occurs. And if vancomycin is
started, it takes a while to become therapeutic; sometimes days.
What was the Gram’s stain?

Dr. Nagarajan: Blood cultures at 48 hours did not show
any growth. The patient was transferred to ICU for hypoxic
respiratory failure, and continued to be short of breath. Sputum
for culture and AFB were obtained. He was placed in respiratory
isolation and started on ceftriaxone and azithromycin.

Dr. Ramirez: You know it’s interesting and I don’t know the
percentage, but we just put an opinion piece in ULJRI (The
University of Louisville Journal of Respiratory Infections)
of how to treat S. aureus pneumonia with bacteremia [4]
We suspect that it is high because S. aureus is an aggressive
pathogen. For pneumococcal pneumonia, bacteremia is 2030% [5], but for S. aureus, we don’t have a value.
I am reminded of when community-acquired MRSA first came
about. This patient reminds me of a 35-year-old female who
was admitted and died. She developed bronchopneumonia,
was admitted to the ward and then transferred to the ICU where
she was intubated and mechanically ventilated. She had an
empyema complicated by a fistula and then she died of multiorgan failure. It took years to establish empiric therapy for
MRSA in CAP patients with risk factors. We actually don’t know
if community-acquired MRSA is more virulent or if communityacquired MRSA becomes worse because coverage for MRSA is
delayed for the first 48 hours.
Who is responsible here? Many pathogens causing pneumonia
are aggressive, and a patient may die if treatment is delayed for
48 hours. There is discussion that receiving antibiotics within 4
hours of presenting to the hospital may be associated with better
outcomes than 8 hours. Imagine not receiving antibiotics for 48
hours! This patient was started on vancomycin on the second
day over 24 hours after presenting to the hospital with a level
that probably wasn’t therapeutic for another day or two.
This patient has bronchopneumonia and now we start seeing
what was a tiny area on the initial X-ray. We can now clearly
see necrotizing pneumonia. At this point, some expert opinions
suggest administering immunoglobulins for this patient,
although there is not data to support its use. The idea is that
since PVL is just one toxin among many that we are exposed
to throughout our lifetime from S. aureus, and to which we
develop antibodies, immunoglobulin therapy may be another
way to treat severe Staphylococcal infection. So this would be
going back in history to give antibodies for pneumonia the same
way they did in the pre-penicillin era.

Management
Dr. Ramirez: This patient was not placed on any anti-MRSA
therapy on day one, except for clindamycin. The discussion in
the emergency room for this patient should have been, “Does
this patient get vancomycin, linezolid or ceftaroline? What is
going to be the MRSA therapy?” Now we recognize that for
community-acquired MRSA, there is not a single antibiotic that
has been FDA approved. We use vancomycin or ceftaroline with
clindamycin for the antitoxin effect, or linezolid, which already
has this effect.
Another point is that the Gram’s stain should be obtained and
evaluated in the emergency room. We have an arrangement
with microbiology that if the Division of Infectious Diseases
orders a Gram’s stain, microbiology will do it stat. If the patient
has S. aureus pneumonia, the Gram’s stain should have grampositive cocci in clusters. This allows us to focus therapy for
MRSA. It is interesting that they ordered clindamycin because
they were considering an anaerobic infection due to aspiration,
but they were actually helping in a different way because of the
partial coverage for MRSA and its toxins.
Dr. Nagarajan: The CT of the chest was read as necrotizing
cavitary pneumonia with septic emboli. His lactic acid
improved to 1.4 mmol/L with intravenous fluids. He continued
to be febrile (102.3°F), tachycardic (128 beats/min), and
tachypneic (28 breaths/min) with a room air saturation of
94%. His antibiotics were changed to vancomycin, clindamycin,
piperacillin/tazobactam and levofloxacin. After 72 hours on the
ward, he was transferred back to ICU, for worsening respiratory
status with a heart rate of 132 beats/min and a temperature of
103.2°F. The sputum culture grew MRSA after 27 hours.
Dr. Ramirez: For the fellows, we get so accustomed to the
patient who is in the age range of 60-97 years. When we have
a patient who is less than 40, we have a totally different type of
patient. This patient who has multi-organ system failure and
evidence of sepsis needs to be monitored closely. Furthermore,
every patient who has sepsis is dehydrated and will improve
slightly with rehydration, but this is not the point. MRSA is
an aggressive form of pneumonia. When does the MRSA stop
necrotizing the lungs? You need three or four days of antibiotics.

Dr. Nagarajan: I didn’t look at it. The blood cultures grew
MRSA three times in four days. His transesophageal echo was
negative for any vegetations.
Dr. Ramirez: We should always look at the Gram’s stains. So,
he had persistent MRSA bacteremia.
Dr. Raff: What percentage of patients with staphylococcal
pneumonia are demonstratively bacteremic?

Dr. Raff: Except they were using horse serum!
Dr. Ramirez: Yes; horse serum. So, here we would be
giving antibiotics, antitoxins and immunoglobulins (meaning
antibodies).
Dr. Nagarajan: The ICU started levofloxacin then de-escalated
antibiotics to only vancomycin.
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Table 2 Vancomycin levels, dosing and creatinine values for specific days
of the patient’s hospitalization.
Day Vancomycin Level Vancomycin Dosing
(µg/mL)
1
2250 mg once
2
12.1
1500 mg q12 hrs
4
8.4
1250 mg q8 hrs
6
12.8
1500 mg q8 hrs
8
9.8
1750 mg q12 hrs
10
9.3
2500 mg q8 hrs
11
19.6
2250 mg q8 hrs

Serum Creatinine
(mg/dL)
1.23
0.98
0.79
0.62
0.59
0.50
0.59

Dr. Ramirez: The point here is that in our study of
community-acquired MRSA pneumonia, there is no study that
is perfect. Linezolid was associated with better outcomes than
vancomycin. But in all the studies comparing vancomycin and
linezolid the question was whether linezolid is actually better or
is vancomycin worse since a level was not therapeutic for the
initial days. If we use vancomycin, we need to give a loading
dose to be sure we get a therapeutic level on day one. And this
is what you had here, except even with the loading dose you
didn’t have a therapeutic level until day four or five. For severely
ill patients with community-acquired MRSA, we cannot be
dependent on an antibiotic if we don’t know that it is therapeutic
on day one. Another point is that we do not typically even get a
level on day one, because we know that the level is going to be
low. Is six hours or eight hours going to make a difference? In
this population, probably so. For these patients we should not
use vancomycin.
Dr. Nagarajan: Pharmacy recommended the dosing. (Table
2) There was a difficulty bringing vancomycin to therapeutic
levels.
Dr. Ramirez: This reminds me of the patients in the trauma
unit years ago who had persistently low levels of aminoglycoside
in the surgical ICU. It didn’t matter how much antibiotic we
gave them, the levels never reached a therapeutic range because
they metabolized it so quickly. Some young people were very
difficult to attain a therapeutic level for an antibiotic. To me, the
drug of choice for MRSA pneumonia is linezolid.
Dr. Nagarajan: He did reach a therapeutic level of 19 µg/
mL on 2.5 g of vancomycin every eight hours on hospital day
# 11. Linezolid was added on day four. And vancomycin was
continued.

Dr. Ramirez: When the community-associated MRSA
epidemic started here, we had a few patients die with
pneumonia. I remember that it was a big debate because
linezolid was still very expensive, and its use was restricted
to the Division of Infectious Diseases. The problem was that
Infectious Diseases was being called on day three, which was
preventing patients from linezolid’s early antitoxin benefit. So,
with the antimicrobial stewardship team, we approached the
emergency department and told them that we wanted them
to use linezolid in a young person with a multilobar infiltrate,
hemoptysis, and neutropenia who was going to be admitted to
the ICU for CAP- and that they did not need Infectious Diseases’
approval. This was because we preferred to stop inappropriate
linezolid after 24 hours rather than have appropriate patients go
without it for 48 hours. We need to reemphasize our use of antiMRSA therapy in the emergency department.
Dr. Nagarajan: The strategy that this division has used in the
past for patients with this diagnosis is summarized in an article
by Dr. Peyrani and Dr. Ramirez. [6].

Anatomical Diagnosis

Post-influenza MRSA pneumonia complicated with bacteremia
and hypoxic respiratory failure.
This case was presented at the University of Louisville Division
of Infectious Diseases Patient Management Conference.
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